Latest News and Press Releases

Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States London, UK 1 March 2021 – Achilles Therapeutics plc (“Achilles” or the...

   Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer - Related patent recently granted and...

   Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer - Related patent recently granted and...

   Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer Stevenage, UK 23 June 2020 – Achilles Therapeutics (“Achilles”), a clinical stage...

   Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer Stevenage, UK 23 June 2020 – Achilles Therapeutics (“Achilles”), a clinical stage...

Achilles Therapeutics appoints Carsten Boess to the Board of Directors Stevenage, UK 7 April, 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage oncology company developing personalised cell...

Achilles Therapeutics appoints Carsten Boess to the Board of Directors Stevenage, UK 7 April, 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage oncology company developing personalised cell...

Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer - Professor Quezada is an internationally recognized leader in the field of cancer immunology and a founder of the...

Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer - Professor Quezada is an internationally recognized leader in the field of cancer immunology and a founder of the...

Achilles Therapeutics Appoints Beverley Carr as Chief Business OfficerBrings 20+ years of business development experience Formerly VP, Business Development for the Immuno-inflammation Therapy Area at...